Recovery of heart function in children with acute severe heart failure

John J O'Sullivan1, Susan L Roche, David S Crossland

  • 1Department of Paediatric Cardiology, Freeman Hospital, Newcastle upon Tyne, United Kingdom. j.j.osullivan@ncl.ac.uk

Transplantation
|April 15, 2008
PubMed

Insights

Complete recovery of left ventricular systolic function in children with acute heart failure often takes over a year. This finding is crucial for determining the optimal timing for heart transplantation in pediatric patients.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Research
  • Pediatric Critical Care Medicine

Background:

  • Acute heart failure in children often necessitates consideration for heart transplantation.
  • Assessing transplant eligibility is complicated by recognized recovery in some cases of dilated cardiomyopathy or myocarditis.
  • Limited data exists on the timeline for heart function recovery in pediatric patients.

Purpose of the Study:

  • To document the echocardiographic recovery timeline of systolic function in children presenting with acute heart failure.
  • To analyze the time course of left ventricular fractional shortening improvement in a pediatric cohort without structural or metabolic abnormalities.

Main Methods:

  • Retrospective analysis of children with a first presentation of acute severe heart failure (1990-2005).
  • Recorded time from presentation to echocardiographic evidence of left ventricular fractional shortening (FS) reaching 20% and 30% (complete recovery).

Main Results:

  • Twenty-seven children with initial FS <15% were analyzed; 21 required inotropes, 3 needed ECMO.
  • Mean time to FS of 20% was 3.6 months, and to 30% was 8.9 months.
  • Complete recovery was achieved by 66% within 12 months and 96% within 24 months; no age correlation found.

Conclusions:

  • Complete recovery of left ventricular systolic function in pediatric acute heart failure can be significantly delayed, often exceeding one year.
  • Delayed recovery impacts critical decisions regarding the timing of heart transplantation, especially with advanced mechanical support options available.
  • These findings highlight the need for careful monitoring and reassessment of transplant candidacy in children with severe heart failure.
Abstract

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...